Trials / Unknown
UnknownNCT05366205
Immune Function in Elderly Patients With Mild to Moderate COVID-19 on Hemodialysis
Prospective, Randomized Controlled Study on Immune Function Regulation by Strengthening Early Oral Nutritional Supplementation in Elderly Patients With Mild to Moderate COVID-19 on Hemodialysis
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 112 (estimated)
- Sponsor
- Ruijin Hospital · Academic / Other
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
This randomized controlled trial will focus on the effects of early oral nutritional supplementation on immune function in elderly patients with mild to moderate COVID-19 on maintenance hemodialysis. The purpose of this study is to determine whether early oral nutritional supplementation can improve immune function and clinical outcomes.
Detailed description
COVID-19 is in the midst of a global pandemic. Elderly patients are often susceptible and at high risk. Elderly patients on maintenance hemodialysis are often accompanied by a variety of complications, malnutrition is a common complication with an incidence of 23-73%. Due to a variety of risk factors, COVID-19 infection tends to develop into severe disease, and it takes longer for nucleic acid to turn negative. This randomized controlled trial will focus on the effects of early oral nutritional supplementation on immune function in elderly patients with mild to moderate COVID-19 on maintenance hemodialysis. The purpose of this study is to determine whether early oral nutritional supplementation can improve immune function and clinical outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Oral nutritional supplement | Enteral nutritional emulsion(TPF-T) will be given by oral intake,400ml per day, lasting for 7-10 days. |
| BEHAVIORAL | Nutrition consultation | Nutritional treatment advice will be given |
Timeline
- Start date
- 2022-05-01
- Primary completion
- 2022-07-31
- Completion
- 2022-08-31
- First posted
- 2022-05-09
- Last updated
- 2022-05-09
Source: ClinicalTrials.gov record NCT05366205. Inclusion in this directory is not an endorsement.